The curious case of the HepG2 cell line: 40 years of expertise

VA Arzumanian, OI Kiseleva… - International journal of …, 2021 - mdpi.com
Liver cancer is the third leading cause of cancer death worldwide. Representing such a
dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable …

Wnt/β-catenin signaling as a driver of hepatocellular carcinoma progression: an emphasis on molecular pathways

M Deldar Abad Paskeh, S Mirzaei… - Journal of …, 2021 - Taylor & Francis
Liver cancers cause a high rate of death worldwide and hepatocellular carcinoma (HCC) is
considered as the most common primary liver cancer. HCC remains a challenging disease …

MYC in liver cancer: mechanisms and targeted therapy opportunities

F Liu, Z Liao, Z Zhang - Oncogene, 2023 - nature.com
MYC, a major oncogenic transcription factor, regulates target genes involved in various
pathways such as cell proliferation, metabolism and immune evasion, playing a critical role …

Wnt/β-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma

RWH Leung, TKW Lee - Cancers, 2022 - mdpi.com
Simple Summary Aberrant Wnt/β-catenin signaling has been reported to play crucial role in
pathogenesis of hepatocellular carcinoma (HCC). In this review, we focus on the regulatory …

System biology-based investigation of Silymarin to trace hepatoprotective effect

PSR Dwivedi, VS Patil, P Khanal, VV Bhandare… - Computers in biology …, 2022 - Elsevier
Silymarin is used as a hepatoprotective agent since ancient times which could be via its
potent anti-oxidant effect. However, the mode of silymarin for the hepatoprotective effect has …

[HTML][HTML] Liquid biopsy using cell-free or circulating tumor DNA in the management of hepatocellular carcinoma

X Lyu, YM Tsui, DWH Ho, IOL Ng - Cellular and Molecular …, 2022 - Elsevier
Liver cancer (hepatocellular carcinoma [HCC]) is a fatal cancer worldwide and often is
detected at an advanced stage when treatment options are very limited. This drives the …

[HTML][HTML] Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: a review

P Mohapatra, N Chandrasekaran - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Liver cancer is the fifth most widespread in the world, with a high fatality rate and poor
prognosis. However, surgicalresction, thermal/radiofrequencyablation, chemo …

[HTML][HTML] Wnt signaling in liver regeneration, disease, and cancer

G Zou, JI Park - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
The liver exhibits the highest recovery rate from acute injuries. However, in chronic liver
disease, the long-term loss of hepatocytes often leads to adverse consequences such as …

Targeting liver cancer stem cells: an alternative therapeutic approach for liver cancer

HY Lee, IS Hong - Cancers, 2020 - mdpi.com
Simple Summary Cancer stem cells (CSCs) are known to be highly resistant to conventional
therapeutic approaches, such as chemotherapeutic drugs and radiation. Therefore …

Dynamics of CD44+ bovine nucleus pulposus cells with inflammation

JR Ferreira, J Caldeira, M Sousa, MA Barbosa… - Scientific Reports, 2024 - nature.com
Intervertebral Disc (IVD) degeneration has been associated with a chronic inflammatory
response, but knowledge on the contribution of distinct IVD cells, namely CD44, to the …